We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
1901
Royalty Pharma
RPRX
$26.4B
$26.2K ﹤0.01%
677
+175
+35% +$6.67K
UTL icon
1902
Unitil
UTL
$1.02B
$26.2K ﹤0.01%
540
+171
+46% +$8.32K
TROX icon
1903
Tronox
TROX
$992M
$26.1K ﹤0.01%
6,267
-4,136
-40% -$15.8K
SIFY
1904
Sify Technologies
SIFY
$1.04B
$26.1K ﹤0.01%
2,143
+189
+10% +$2.3K
GLNG icon
1905
Golar LNG
GLNG
$4.97B
$26K ﹤0.01%
699
-136
-16% -$5.2K
FIVN icon
1906
FIVE9
FIVN
$2.08B
$26K ﹤0.01%
1,295
+516
+66% +$11K
UNIT
1907
Uniti Group
UNIT
$2.54B
$25.9K ﹤0.01%
3,696
-754
-17% -$4.78K
KWR icon
1908
Quaker Houghton
KWR
$2.7B
$25.8K ﹤0.01%
188
+5
+3% +$675
HTO
1909
H2O America
HTO
$2.72B
$25.7K ﹤0.01%
525
+347
+195% +$16.6K
RCUS icon
1910
Arcus Biosciences
RCUS
$3.37B
$25.7K ﹤0.01%
1,079
SRPT icon
1911
Sarepta Therapeutics
SRPT
$1.62B
$25.6K ﹤0.01%
1,188
-23
-2% -$485
NUVB icon
1912
Nuvation Bio
NUVB
$2.28B
$25.6K ﹤0.01%
2,853
SFNC icon
1913
Simmons First National
SFNC
$3.37B
$25.6K ﹤0.01%
1,356
-6
-0.4% -$111
AHRT
1914
AH Realty Trust
AHRT
$545M
$25.5K ﹤0.01%
3,852
-12,729
-77% -$84K
NWPX icon
1915
NWPX Infrastructure Inc
NWPX
$1.2B
$25.4K ﹤0.01%
407
NSSC icon
1916
Napco Security Technologies
NSSC
$1.33B
$25.3K ﹤0.01%
607
PAGP icon
1917
Plains GP Holdings
PAGP
$5.18B
$25.3K ﹤0.01%
1,320
ASTS icon
1918
AST SpaceMobile
ASTS
$16.8B
$25.1K ﹤0.01%
346
+37
+12% +$2.64K
UCTT
1919
Ultra Clean Holdings
UCTT
$3.48B
$25.1K ﹤0.01%
989
+284
+40% +$7.56K
ALAB icon
1920
Astera Labs
ALAB
$44.6B
$25K ﹤0.01%
150
+5
+3% +$836
AIQ icon
1921
Global X Artificial Intelligence & Technology ETF
AIQ
$9.1B
$24.9K ﹤0.01%
490
IRDM icon
1922
Iridium Communications
IRDM
$4.8B
$24.9K ﹤0.01%
1,430
+741
+108% +$13.1K
FOR icon
1923
Forestar Group
FOR
$1.5B
$24.8K ﹤0.01%
1,008
CRAI icon
1924
CRA International
CRAI
$1.17B
$24.7K ﹤0.01%
123
-11
-8% -$2.07K
AXSM icon
1925
Axsome Therapeutics
AXSM
$12B
$24.7K ﹤0.01%
135

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.